Nathan Brown
@nathanbroon
Director of Digital Chemistry @healx • Chair @UKQSAR • FRSA FRSB FRSC • 🏴🇩🇰🇪🇺
From shared vision to changing lives. In 2013, our co-founders Dr. David Brown & Tim Guilliams met for the first time — a conversation that sparked the creation of Healx and a new approach to discovering and developing treatments for rare diseases. Now, we’ve just dosed the first…
In honor of International Day of Women and Girls in Science, we’re celebrating the incredible women at Healx who are helping to pave the way in AI-driven drug discovery for #rarediseases. We believe in fostering a more inclusive future where women and girls are empowered to shape…
Our co-founder and CEO Tim Guilliams is looking forward to participating in a panel discussion on how #AI is reshaping healthcare at @Balderton’s “From code to cure: AI's reshaping of drug discovery” event in London. Tim will highlight how Healx is leveraging generative AI to…
Great to have Jonathan stepping up as non-executive chairman at Healx as Dave goes on secondment!
We are pleased to announce the appointment of Jonathan Milner, Ph.D., as the new non-executive chairman of the board, effective immediately. Dr. Milner is a distinguished entrepreneur and an influential figure in the UK life sciences and #biotech industry with a strong track…
🚀 Healx is launching a new blog series on practical, open-source workflows for drug discovery! First up: a KNIME + ChEMBL pipeline to explore compound-target interactions. Big thanks to #RDKit, ChEMBL, UniChem & KNIME! 🧪 Read more: medium.com/low-code-for-a…
Spring UK-QSAR meeting: Registration is now open! Find out more here ukqsar.org/index.php/2025… 📆 Tuesday 15th April 2025 📍Francis Crick Institute, London #ukqsar #compchem #cheminformatics #chemoinformatics
🚀 Big milestone! The first patient has been dosed in INSPIRE-NF1, our Phase 2 study of HLX-1502 for #NF1, a rare genetic disorder affecting ~1 in 2,500 people. This is a huge step forward in our mission to use #AI & tech to drive breakthroughs for #raredisease patients. Hear…
The new issue of @RSC_CICAG Distillate has been published. It’s full Of useful information and updates: rsccicag.org/index_htm_file… #cheminformatics #chemoinformatics #compchem #medchem
Excited for #JPM25 next week in San Francisco! Our CEO, Tim Guilliams, will be there—say hello if you see him! Let’s connect to share insights and collaborate on transforming lives for #raredisease patients through generative #AI. #AIForGood #HealthcareInnovation…
Another quarterly team days meeting in the books! We enjoyed coming together in Cambridge one final time before the end of the year to reflect on the progress made in 2024 and the strides we have made in leveraging the power of generative AI to bring new treatments to patients.…
Working with Dave is inspirational and he always has fascinating insights. Congratulations, Dave!
We're extending our sincerest congratulations to Healx Co-founder David Brown, Ph.D., for being awarded the 2024 @OBN_UK Awards Special Recognition Award. Over the span of 50 years, and in addition to his leadership at Healx, he has worked with leading pharmaceutical companies…
I’m moving to #Bluesky #bsky. Follow me here if you like: bsky.app/profile/nathan…
I’m planning to move over to #bluesky in the near future. You can follow me here if you like: bsky.app/profile/nathan… I’ll probably keep this active as an archive but likely no new posts
Amazing performance by #TimothyWest in Tales of the Unexpected: Royal Jelly youtu.be/FFlMZxjoSCE
Terrific news for @healx and more validation of our technologies #TogetherWeHeal #TeamHealx #AIforGood
Our Senior Director, Drug Discovery and Head of Operations, People & Tech will be participating in the @OBN_UK BioTuesday session next week in London. They will contribute to a conversation about the funding landscape and regulatory challenges within the #raredisease space and…